MX362405B - Composiciones y metodos para procedimientos de fusion de espina. - Google Patents

Composiciones y metodos para procedimientos de fusion de espina.

Info

Publication number
MX362405B
MX362405B MX2013006697A MX2013006697A MX362405B MX 362405 B MX362405 B MX 362405B MX 2013006697 A MX2013006697 A MX 2013006697A MX 2013006697 A MX2013006697 A MX 2013006697A MX 362405 B MX362405 B MX 362405B
Authority
MX
Mexico
Prior art keywords
spine fusion
methods
compositions
fusion procedures
spine
Prior art date
Application number
MX2013006697A
Other languages
English (en)
Spanish (es)
Other versions
MX2013006697A (es
Inventor
E Lynch Samuel
B Snel Leo
K Hee Christopher
Original Assignee
Biomimetic Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomimetic Therapeutics Llc filed Critical Biomimetic Therapeutics Llc
Publication of MX2013006697A publication Critical patent/MX2013006697A/es
Publication of MX362405B publication Critical patent/MX362405B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Materials Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Composite Materials (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2013006697A 2010-12-13 2011-12-13 Composiciones y metodos para procedimientos de fusion de espina. MX362405B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42264910P 2010-12-13 2010-12-13
PCT/US2011/064698 WO2012082773A1 (en) 2010-12-13 2011-12-13 Compositions and methods for spine fusion procedures

Publications (2)

Publication Number Publication Date
MX2013006697A MX2013006697A (es) 2013-10-30
MX362405B true MX362405B (es) 2019-01-15

Family

ID=46245079

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013006697A MX362405B (es) 2010-12-13 2011-12-13 Composiciones y metodos para procedimientos de fusion de espina.

Country Status (10)

Country Link
US (2) US20140308332A1 (cg-RX-API-DMAC7.html)
EP (1) EP2651319A4 (cg-RX-API-DMAC7.html)
JP (3) JP6116484B2 (cg-RX-API-DMAC7.html)
KR (3) KR20200055149A (cg-RX-API-DMAC7.html)
CN (2) CN103491888A (cg-RX-API-DMAC7.html)
AU (1) AU2011343995A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013014686A2 (cg-RX-API-DMAC7.html)
CA (1) CA2819258C (cg-RX-API-DMAC7.html)
MX (1) MX362405B (cg-RX-API-DMAC7.html)
WO (1) WO2012082773A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2654796A1 (en) 2010-12-21 2013-10-30 Koninklijke Philips N.V. Agents for clearing biomolecules from circulation
WO2016043955A1 (en) * 2014-08-28 2016-03-24 Bioventus, Llc Improved osteoinductive substrates and methods of making the same
CN107106492B (zh) 2014-10-14 2022-07-05 塞缪尔·林奇 用于治疗伤口的组合物
JP2018500135A (ja) 2014-12-29 2018-01-11 バイオヴェンタス・エルエルシー 骨修復における骨誘導分子の改善された送達システム及び方法
WO2017019959A1 (en) * 2015-07-30 2017-02-02 Clarion Research Group Formulations and methods for recovery from spinal surgery
EP3368094B1 (en) 2015-10-30 2021-03-10 Bioventus LLC Matrix for enhanced delivery of osteoinductive molecules in bone repair
US12318475B2 (en) 2016-03-14 2025-06-03 The University Of Chicago Injectable pastes based on oppositely charged polymer/calcium phosphate nanoparticles
JP2019518550A (ja) 2016-06-10 2019-07-04 バイオヴェンタス・エルエルシー 多孔質金属構造物でのタンパク質送達
WO2019014576A1 (en) * 2017-07-14 2019-01-17 The University Of Chicago LYOPHILIZED FORMULATIONS COMPRISING NANOPARTICLES AND METHODS OF LYOPHILIZATION
JP2022525168A (ja) * 2019-03-14 2022-05-11 バイオミメティック セラピューティクス，リミテッド ライアビリティ カンパニー 骨癒合を増強するための血小板由来増殖因子製剤
EP3795185A1 (en) * 2019-09-23 2021-03-24 Kuros Biosurgery AG Bone graft material for use in a spinal fusion method
CN111481741A (zh) * 2020-04-15 2020-08-04 花沐医疗科技(上海)有限公司 复合可吸收自锁定颈椎融合器及其制备方法
KR102667977B1 (ko) 2020-05-08 2024-05-22 주식회사 에이치엘클레무브 차량용 레이더 장치 및 제어방법
WO2025042830A1 (en) 2023-08-18 2025-02-27 Biomimetic Therapeutics, Llc Platelet-derived growth factor bone graft putty formulation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010037091A1 (en) * 1999-12-29 2001-11-01 Wironen John F. System for reconstituting pastes and methods of using same
DE60137073D1 (de) * 2000-10-24 2009-01-29 Warsaw Orthopedic Inc Vorrichtungen für die spinalfusion
AU2004212942A1 (en) * 2003-02-14 2004-09-02 Depuy Spine, Inc. In-situ formed intervertebral fusion device
US20040193270A1 (en) * 2003-03-31 2004-09-30 Depuyacromed, Inc. Implantable bone graft
CN1640368A (zh) * 2004-01-06 2005-07-20 宋跃明 椎间融合装置
US7901650B2 (en) * 2005-06-22 2011-03-08 Skeletal Kinectics, LLC Porous beta-tricalcium phosphate and methods for producing the same
EP2431060B1 (en) * 2005-11-17 2020-04-08 BioMimetic Therapeutics, LLC Maxillofacial bone augmentation using RHPDGF-BB and a biocompatible matrix
JP5068269B2 (ja) * 2005-12-14 2012-11-07 シル テクノロジー ゲーエムベーハー 骨再生のための成形可能な生体材料
WO2008151193A1 (en) * 2007-06-04 2008-12-11 Biomimetic Therapeutics, Inc. Compositions and methods for treating the vertebral column
US9161967B2 (en) * 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
AU2007333425B2 (en) * 2006-11-03 2014-03-27 Stryker Corporation Compositions and methods for arthrodetic procedures
US8241357B2 (en) * 2007-04-25 2012-08-14 Jmea Corporation Prosthesis with a selectively applied bone growth promoting agent
US20090048675A1 (en) * 2007-04-25 2009-02-19 Bhatnagar Mohit K Spinal Fusion Implants with Selectively Applied Bone Growth Promoting Agent
CN101121753B (zh) * 2007-06-06 2011-11-16 天津林达生物科技有限公司 对多种皮肤细胞修复具持续作用的人血清白蛋白重组融合蛋白
CA2698017C (en) * 2007-08-29 2016-12-13 Etex Corporation Bone cement mixing and delivery system and methods of use thereof
CN105854074B (zh) * 2008-02-07 2019-10-15 生物模拟治疗有限责任公司 用于牵引成骨术的组合物和方法
JP2012519556A (ja) * 2009-03-05 2012-08-30 バイオミメティック セラピューティクス， インコーポレイテッド 骨軟骨欠損を治療するための血小板由来増殖因子組成物および方法

Also Published As

Publication number Publication date
AU2011343995A1 (en) 2013-06-20
JP2018161541A (ja) 2018-10-18
EP2651319A1 (en) 2013-10-23
CA2819258C (en) 2020-03-10
JP6116484B2 (ja) 2017-04-19
JP2017018710A (ja) 2017-01-26
MX2013006697A (es) 2013-10-30
KR20140038348A (ko) 2014-03-28
JP2013545584A (ja) 2013-12-26
US20140308332A1 (en) 2014-10-16
CA2819258A1 (en) 2012-06-21
CN108498873A (zh) 2018-09-07
KR20180121674A (ko) 2018-11-07
EP2651319A4 (en) 2016-08-17
CN103491888A (zh) 2014-01-01
WO2012082773A1 (en) 2012-06-21
US20190365946A1 (en) 2019-12-05
BR112013014686A2 (pt) 2016-10-04
KR20200055149A (ko) 2020-05-20

Similar Documents

Publication Publication Date Title
MX362405B (es) Composiciones y metodos para procedimientos de fusion de espina.
WO2008073628A3 (en) Compositions and methods for arthrodetic procedures
WO2011137292A3 (en) Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering
WO2012002986A3 (en) Decellularized and delipidized extracellular matrix and methods of use
AU2016204295A1 (en) Compositions and methods for promoting bone formation
MX2009013970A (es) Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos.
GB2497475A (en) Kits, components and methods for tissue reconstruction
WO2013009784A9 (en) Systems and method for accelerating healing of implanted material and/or native tissue
WO2013070881A8 (en) Method for elimination of space through tissue approximation
AU2014290512A8 (en) Methods, systems, and compositions for promoting bone growth
WO2012003465A3 (en) Scaffold-free three dimensional nerve fibroblast constructs
HRP20190222T1 (hr) Pripravak za popravljanje hrskavičnog tkiva, postupak njegove priprave i njegova upotreba
WO2012170417A3 (en) Methods and compositions to enhance bone growth comprising a statin
WO2011109433A9 (en) Tissue for prosthetic implants and grafts, and methods associated therewith
EP2370110A4 (en) INTRA-OCULAR TISSUE MARKING COMPOSITION, INTRA-OCULAR TISSUE MARKING METHOD, AND SCREENING METHOD
EP2846716B8 (en) Implant for fixation of first and second bones
WO2012048170A3 (en) Humanized animals via tissue engineering and uses therefor
PH12015500226A1 (en) Compositions and methods for the treatment of bone voids and open fractures
WO2012065173A3 (en) Methods and devices for soft tissue and joint repair
PL2932989T3 (pl) Uszczelniacz tkankowy, w którym zmieszane są kolagen i fibryna oraz sposób jego wytworzenia
GB201519048D0 (en) Method and apparatus for performing spinal surgery
PT2259804T (pt) Método para a produção de uma composição óssea implantável
PL391482A1 (pl) Sposób otrzymywania produktu inżynierii tkankowej do rekonstrukcji i regeneracji tkanki kostnej, produkt inżynierii tkankowej oraz jego zastosowanie
WO2012051165A3 (en) Mir-211 expression and related pathways in human melanoma
WO2011050099A3 (en) Therapeutic composition

Legal Events

Date Code Title Description
FG Grant or registration